Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dow Corning breast implant report

This article was originally published in The Gray Sheet

Executive Summary

Judge Samuel Pointer of the U.S. District Court in Birmingham, Alabama rules that the report prepared by former Attorney General Griffen Bell on the company's breast implant business is confidential under the attorney/client relationship and does not have to be released to the public or FDA, according to Dow. The agency had asked the company to release the report ("The Gray Sheet" Jan. 18, I&W-4). Judge Pointer, who has multi-district responsibility for silicone breast implant lawsuits, rendered the decision at a recent pre-trial conference in Washington, D.C. The next conferences are scheduled for Feb. 24 in San Francisco and March 25 in Birmingham, Alabama.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000162

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel